-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$495,115
Zentalis Pharmaceuticals, Inc. Insider Transactions
Zentalis Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Vultaggio Vincent
Principal Accounting Officer |
Sell | 1,603 @ $3.18 | $5,098 | 33,855 | 10/04/2024 | 10/04/2024 | |
|
Gallagher Cam
Director, President, Interim CFO |
Sell | 9,597 @ $11.98 | $114,972 | 633,680 | 05/31/2024 | 05/31/2024 | |
|
HAUSMAN DIANA
Chief Medical Officer |
Sell | 3,356 @ $12.62 | $42,353 | 373,876 | 05/09/2024 | 05/09/2024 | |
| Sell | 2,573 @ $11.44 | $29,435 | 451,449 | 02/12/2024 | 02/12/2024 | ||
|
Gallagher Cam
Director, President |
Sell | 1,173 @ $11.44 | $13,419 | 643,277 | 02/12/2024 | 02/12/2024 | |
|
Lackner Mark
Chief Scientific Officer |
Sell | 1,585 @ $11.54 | $18,291 | 195,728 | 02/02/2024 | 02/05/2024 | |
|
Paul Andrea
Chief Legal Officer |
Sell | 3,310 @ $11.54 | $38,197 | 149,973 | 02/02/2024 | 02/05/2024 | |
|
Gallagher Cam
Director, President |
Sell | 11,552 @ $11.54 | $133,310 | 644,450 | 02/02/2024 | 02/05/2024 | |
| Sell | 8,669 @ $11.54 | $100,040 | 454,022 | 02/02/2024 | 02/05/2024 | ||
| Buy | 5,000 @ $10.29 | $51,448 | 254,800 | 11/13/2023 | 11/13/2023 | ||
|
Johnson David Michael
Director |
Buy | 17,000 @ $9.88 | $167,943 | 144,389 | 11/10/2023 | 11/13/2023 | |
|
Brownstein Carrie
Chief Medical Officer |
Sell | 8,906 @ $19.43 | $173,012 | 107,407 | 10/04/2023 | 10/06/2023 | |
|
Brownstein Carrie
Chief Medical Officer |
Sell | 1,722 @ $19.91 | $34,285 | 105,685 | 10/04/2023 | 10/06/2023 | |
|
Bunker Kevin D.
Chief Scientific Officer |
Sell | 5,085 @ $19.43 | $98,784 | 860,072 | 10/04/2023 | 10/06/2023 | |
|
Bunker Kevin D.
Chief Scientific Officer |
Sell | 983 @ $19.91 | $19,572 | 859,089 | 10/04/2023 | 10/06/2023 | |
| Sell | 4,594 @ $19.43 | $89,245 | 388,579 | 10/04/2023 | 10/06/2023 | ||
| Sell | 888 @ $19.91 | $17,680 | 387,691 | 10/04/2023 | 10/06/2023 | ||
|
Skvarka Jan
Director |
Sell | 5,000 @ $25.05 | $125,238 | 47,970 | 09/11/2023 | 09/13/2023 | |
|
Matrix Capital Management Company, LP
10 percent owner |
Buy | 4,760,000 @ $22.66 | $107.86 M | 13,959,973 | 06/20/2023 | 06/20/2023 | |
|
Gallagher Cam
Director, President |
Sell | 9,242 @ $26.40 | $243,979 | 482,028 | 05/31/2023 | 05/31/2023 |
Zentalis Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Zentalis Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Zentalis Pharmaceuticals, Inc. includes Epperly Melissa B,, Gallagher Cam, Paul Andrea, Lackner Mark, HAUSMAN DIANA, Vultaggio Vincent.
-
How much insider selling is happening at Zentalis Pharmaceuticals, Inc.?
Insiders have sold a total of 43,418 Zentalis Pharmaceuticals, Inc. shares in the last 12 months for a total of 495,115 sold.
-
Which Zentalis Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Zentalis Pharmaceuticals, Inc. shares in the last 12 months: Epperly Melissa B, ($129,475), Gallagher Cam ($261,701), Paul Andrea ($38,197), Lackner Mark ($18,291), HAUSMAN DIANA ($42,353), Vultaggio Vincent ($5,098),